Aviva is up nearly 4% and significantly outperforming the trend in London, on the back of favorable comments from UBS, which reaffirms its 'buy' recommendation with a price target raised from 590 to 675 pence on the insurance company's shares.

Aviva is our first choice in life insurance, with an attractive return on capital of around 40% over the next three years", explains the broker, adding that the benefits of the Direct Line acquisition have not been factored into the share price.

Copyright (c) 2025 CercleFinance.com. All rights reserved.